Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Célia Lloret-Linares, MD PhD, Hopital Lariboisière
ClinicalTrials.gov Identifier:
NCT01813292
First received: March 12, 2013
Last updated: November 21, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2014
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)